DAIC

APRIL 7, 2025

tim.hodson Mon, 04/07/2025 - 16:15 April 4, 2025 Viz.ai has been named an Award Winner in the 2025 Edison Awards, for the third year in a row. The Edison Awards, named after the American inventor Thomas Alva Edison, honor excellence in new product and service development, marketing, design and innovation.

Academic 52

Academic Innovation Cardiomyopathy Electrocardiogram 52

DAIC

JANUARY 30, 2025

tim.hodson Thu, 01/30/2025 - 15:31 Jan. 29, 2025 Researchers atOchsner Health, led byHernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence. For information please visit Reference: Bazan HA et al.

Stroke 52

Stroke Strokes Outcomes Quality of Life 52

American Heart News - Heart News

FEBRUARY 18, 2025

18, 2025 Five regions in the U.S. DALLAS, Feb. have been selected to implement a new preventive health initiative to improve care for people with a cluster of chronic conditions known as cardiovascular-kidney-metabolic (CKM) syndrome. Through the.

Innovation 84

Innovation 84

Society of Thoracic Surgeons - Congenital

JANUARY 2, 2025

Event 2025 STS Coronary Conference gmckinney Thu, 01/02/2025 - 10:57 Event dates Jun 1214, 2025 Location Chicago, IL The 2025 STS Coronary Conference is an innovative international event taking place June 12-14, in Chicago. Abstract submissions will begin soon!

Cardiothoracic 52

Cardiothoracic Innovation 52

DAIC

JANUARY 7, 2025

tim.hodson Tue, 01/07/2025 - 10:01 Jan. 7, 2025 FIRE1 recently announced it has received Breakthrough Device Designation from the U.S. The Norm heart failure self-management system is a first-of-its-kind innovation that empowers patients to take greater control of their health.

Heart Failure 64

Heart Failure Chronic Disease Innovation Technology 64

International Journal of Cardiovascular Sciences

MARCH 27, 2025

The International Journal of Cardiovascular Sciences has extended the deadline for article submissions to the special issue on Artificial Intelligence in Cardiovascular Health until August 30, 2025 ! Publications in this collection will continue until December 2025. Erito Marques de Souza Filho and Roberto Botelho.

Article 52

Article Innovation Education Research 52

DAIC

JULY 29, 2024

mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. JenaValve presented positive results of its U.S.

Innovation 105

Innovation Aortic valve Aortic CMS 105

American College of Cardiology

JANUARY 6, 2025

As the new year begins, the landscape of cardiovascular medicine is undergoing a remarkable transformation, driven by groundbreaking technologies and innovative approaches that promise to revolutionize patient care.

Innovation 66

Innovation Technology Patient Care Article 66

DAIC

MARCH 25, 2025

tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Bayer Pharmaceuticals.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

DAIC

APRIL 4, 2025

Source: Tower Health tim.hodson Fri, 04/04/2025 - 10:03 April 3, 2025 Tower Health and Siemens Healthineers recently announced a 10-year agreementfocused on equipment enhancement, technology modernization and improving clinical experience for patients. Reading Hospital, part of the Tower Health healthcare system.

Patient Care 52

Patient Care Technology Innovation Cardiovascular Imaging 52

CardiacWire

APRIL 2, 2025

The ACC 2025 meeting is all wrapped up after matching the attendance and excitement of last years expo, with a clear trend toward better diagnostics and even better pharmaceuticals. Among dozens of highlights, here are Cardiac Wires seven biggest trends from ACC.25. Diverse Pharma ACC.25

Reimbursement 64

Reimbursement TAVR Research Innovation 64

American Heart News - Heart News

FEBRUARY 28, 2025

28, 2025 Cardiovascular disease disproportionately affects Black communities, with more than 57% of non-Hispanic Black adults living with some form of the disease. DALLAS, Feb. To drive solutions that address these disparities, the American Heart.

Innovation 61

Innovation Cardiovascular Disease 61

DAIC

MARCH 27, 2025

tim.hodson Thu, 03/27/2025 - 15:40 March 27, 2025 GE HealthCare is announcing theU.S.launch of Flyrcado(flurpiridaz F 18) injection at the 2025American College of Cardiology(ACC) AnnualScientific Session & Expo inChicago. Flyrcado is aunit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent.

Coronary Artery Disease 52

Coronary Artery Disease CMS Innovation Ischemia 52

HCPLive

JANUARY 23, 2025

In this episode, hosts explore the latest updates to the ADA Standards of Care on therapeutic innovations and their real-world impact on diabetes management.

Diabetes 59

Diabetes Innovation 59

Cardiometabolic Health Congress

OCTOBER 10, 2024

These innovative companies leverage AI to develop cutting-edge diagnostic tools, predictive analytics, and personalized medicine approaches. This exciting overview highlights the top 10 AI-powered cardiometabolic startups poised to make significant impacts in 2025.

Innovation 52

Innovation Technology Kidney Disease Chronic Disease 52

DAIC

FEBRUARY 18, 2025

tim.hodson Tue, 02/18/2025 - 10:08 Feb. 13, 2025 Research from Cedars-Sinai investigators and collaborators at other leading medical institutions is helping to provide more treatment options to people living with tricuspid valve disease. Image by Getty.

Tricuspid 52

Tricuspid Open-Heart Surgery Quality of Life Anatomy 52

DAIC

FEBRUARY 18, 2025

tim.hodson Tue, 02/18/2025 - 16:17 Feb. 11, 2025 UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound,recentlyannounced support from Bristol Myers Squibb (BMS) for a study that aims to improve access to echocardiographic assessments for patients with obstructive hypertrophic cardiomyopathy (oHCM).

Ultrasound 52

Ultrasound Echocardiogram Innovation Cardiomyopathy 52

DAIC

FEBRUARY 12, 2025

tim.hodson Wed, 02/12/2025 - 15:04 Feb. 12, 2025 On Feb. 11, 2025, at HonorHealth Research Institute, Rahul Doshi, M.D., Through clinical trials, we remain committed to advancing cutting edge technology and innovative therapy to improve patient care." among the clinical trials 32 sites nationwide.

AFIB 52

AFIB Research Ablation Atrial Fibrillation 52

DAIC

APRIL 8, 2025

David Luria (left), Director of Electrophysiology at Hadassah Medical Center, and Ziv Menshes (right), CEO of CardioVia tim.hodson Tue, 04/08/2025 - 14:38 April 7, 2025 CardioVia, a medical device company specializing in advanced cardiac care solutions, has received U.S. According to expert estimates, millions of people in the U.S.

Electrophysiology 52

Electrophysiology Arrhythmia Innovation Technology 52

DAIC

MAY 31, 2024

Joaquin Duato , Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally. in 2024 and approximately $0.17

Peripheral Arterial Disease 104

Peripheral Arterial Disease Innovation Coronary Artery Disease Cardiovascular Interventions 104

DAIC

MARCH 12, 2025

tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrial fibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.

Ablation 52

Ablation Innovation Quality of Life Atrial Fibrillation 52

DAIC

FEBRUARY 14, 2025

Lorraine and Bill Dodero tim.hodson Fri, 02/14/2025 - 15:33 Feb. 10, 2025 A generous gift of $5 million from Lorraine and Bill Dodero will establish the Lorraine and Bill Dodero Limb Preservation Center at University Hospitals Harrington Heart & Vascular Institute in Cleveland, Ohio. When we save a limb, we save a life.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Cancer Innovation Best Practices 52

DAIC

JANUARY 29, 2025

tim.hodson Wed, 01/29/2025 - 11:11 Jan. 28, 2025 Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the TemboEmbolic System.

Embolism 52

Embolism Innovation Research 52

DAIC

FEBRUARY 14, 2025

tim.hodson Fri, 02/14/2025 - 14:32 Feb. tim.hodson Fri, 02/14/2025 - 14:32 Feb. Senior Vice President of Medical Affairs and Innovation at Orchestra BioMed. The presentation,"Effects of Atrioventricular Interval Modulation (AVIM) Therapy in Subjects with Hypertension and Diastolic Dysfunction,"was deliveredby Marat Fudim, M.D.,

Blood Pressure 52

Blood Pressure Heart Failure Hypertension Technology 52

DAIC

JANUARY 8, 2025

tim.hodson Wed, 01/08/2025 - 14:11 Jan. 8, 2025 Mineralys Therapeutics, Inc., The Company anticipates initiating the trial in the first quarter of 2025. I look forward to conducting this innovative trial with Mineralys and our academic partners over the coming months.

Blood Pressure 52

Blood Pressure Hypertension Kidney Disease BMI 52

DAIC

FEBRUARY 3, 2025

tim.hodson Mon, 02/03/2025 - 12:30 January 29, 2025 Roche announced today that the Tina-quant Lipoprotein (a) Gen.2 Roche has an unrivaled ability to provide access to testing at scale and is committed to advancing innovation in preventive cardiology. This will be the first 510(k) cleared test of its kind available in the U.S.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

DAIC

MARCH 24, 2025

tim.hodson Mon, 03/24/2025 - 15:48 March 24, 2025 Imperative Care, Inc. In my early experience, Ive been able to consistently achieve 97% clot removal in, on average, two passes, with minimal blood loss ( This latest innovation expands the Symphony Thrombectomy System offering to include 16F 82cm, 16F 117cm and 24F 85cm catheters.

Blood Clot 52

Blood Clot Vascular Care Technology Thrombosis 52

DAIC

JULY 15, 2024

Combined with Edwards’ existing mitral innovations, the acquisition enhances the company’s TMVR technologies to address large unmet structural heart patient needs and support sustainable long-term growth. Edwards’ SAPIEN M3 remains on track to become the first approved transfemoral TMVR system in Europe by the end of 2025.

Bicuspid/Mitral 105

Bicuspid/Mitral Tricuspid Technology Innovation 105

DAIC

JANUARY 30, 2025

tim.hodson Thu, 01/30/2025 - 15:12 Penumbra recently launched its Element Vascular Access System , a laser-cut hypotube sheath designed for venous thromboembolism (VTE). Innovative Valve Technology Element features the HemoLockValve System, designed to ensure hemostasis through dual-valve engineering.

Technology 52

Technology Anatomy Embolism Innovation 52

CardiacWire

FEBRUARY 6, 2025

Innovation across specialties Digital pathology leadership: Through partnership with Leica Biosystems, Sectra is the only IMS (Image Management System) with FDA clearance for primary diagnostics using DICOM in digital pathology. But Sectra isn’t a one-trick pony.

Innovation 52

Innovation Echocardiogram Pediatrics Outcomes 52

DAIC

MARCH 28, 2025

tim.hodson Fri, 03/28/2025 - 15:23 Mar. This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. For more information on Revolution Vibe, please visit gehealthcare.com.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

CardiacWire

FEBRUARY 21, 2025

Competition breeds innovation, and thats good news for ATTR-CM patients who could have three different drugs to choose from: Vyndaqel (Pfizer), Attruby/Beyonttra (BridgeBio), and Amvuttra (Alnylam). ATTR-CM affects more than 120k Americans with 5-7k new cases each year, but underdiagnosis means there could be even more.

Innovation 59

Innovation Heart Failure Research Outcomes 59

DAIC

JANUARY 24, 2025

tim.hodson Fri, 01/24/2025 - 11:03 Jan. 22, 2025 Anthos Therapeutics, Inc., 2025 If you enjoy this content, please share it with a colleague Nat Rev Cardiol. Colilla S et al.Am Hsu J et al JAMA Cardiol. Yao C et al. Pokorney SD et al. Am Heart J. Ruff C et al. N Engl J Med.

AFIB 52

AFIB Atrial Fibrillation General Cardiology Stroke 52

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has released clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. Budoff, M.D.,

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart attacks 52

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 15:02 March 31, 2025 iRhythm Technologies, Inc. has announced results from two large real-world retrospective analyses presented at the American College of Cardiology (ACC) 2025 Scientific Sessions in Chicago. iRhythm Technologies, 2025. Drawing on data from more than 1.1 14 Data on file.

Arrhythmia 52

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP77-AWP77, February 1, 2025. Background:Strokes can occur anywhere in the hospital and stroke codes are not limited to dedicated stroke units. Despite this, most educational resources are focused on stroke-specific units rather than on all inpatient nursing areas. on non-stroke units.

Nursing 40

Nursing Education Innovation Strokes 40

DAIC

JANUARY 28, 2025

Faubert and Shang Wang, Stevens Institute of Technology tim.hodson Tue, 01/28/2025 - 10:45 Jan. 2025 Researchers have developed a new software tool that provides unprecedented capabilities to see inside 3D images. Credit : Andre C.

Research 52

Research Congenital Technology Congenital Heart Disease 52